Somatostatin Receptor 2 Expression Profiles and Their Correlation with the Efficacy of Somatostatin Analogues in Gastrointestinal Neuroendocrine Tumors

SIMPLE SUMMARY: Immunolocalization of somatostatin receptor 2 (SSTR2) could predict the therapeutic efficacy of somatostatin analogues (SSAs) in neuroendocrine tumors (NETs). Therefore, in this study, we evaluated SSTR2 immunoreactivity and elucidated its correlation with clinicopathological variabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Hirofumi, Fujishima, Fumiyoshi, Komoto, Izumi, Imamura, Masayuki, Hijioka, Susumu, Hara, Kazuo, Yatabe, Yasushi, Kudo, Atsushi, Masui, Toshihiko, Tsuchikawa, Takahiro, Sakamoto, Kazuhiro, Shiga, Hisashi, Nakamura, Tomohiro, Nakaya, Naoki, Motoi, Fuyuhiko, Unno, Michiaki, Sasano, Hironobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834049/
https://www.ncbi.nlm.nih.gov/pubmed/35159042
http://dx.doi.org/10.3390/cancers14030775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834049/
https://www.ncbi.nlm.nih.gov/pubmed/35159042
http://dx.doi.org/10.3390/cancers14030775

Ejemplares similares